* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Eisai Co.

Eisai Introduces Chocola BB? Drink bit, New Pharmaceutical Drink for Acne and Skin Care

pharmiweb.co.uk
yesterday
        

Eisai Introduces “Chocola BB® Drink bit”, New Pharmaceutical Drink for Acne and Skin Care Eisai Co., Ltd. (Headquarters: Tokyo; President & CEO: Haruo Naito) announced today that it will launch a new over-the-counter product...

add comment
                   

Eisai Introduces 'Chocola BBR Drink bit', New Pharmaceutical Drink for Acne and Skin Care

pharmiweb.co.uk
Oct 8, 2008
        

(JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo; President & CEO: Haruo Naito) announced today that it will launch a new over-the-counter product "Chocola BBR Drink bit," a 50 mL vitamin B2-based pharmaceutical drink, on...

add comment
                   

Nikkei touches 3-year low, economy worry hits hard

reuters.com
Oct 3, 2008 20 related
        

TOKYO (Reuters) - Japan's Nikkei stock average slid 1.5 percent to a three-year low on Friday as growing worries about the global economy hit automakers and exporters such as Canon Inc Toyota Motor Co fell to a three-year low...

add comment

TorreyPines Closing Discovery Arm to Focus on Development

tmcnet.com
Sep 25, 2008 1 related
        

Nycomed Shutting Three Plants TorreyPines Therapeutics Inc. is ditching its drug discovery operations and cutting staff 50 percent, in the second round of cutbacks this year. The San Diego-based company also will seek to...

add comment
                   

New Alzheimer's Disease Survey Reveals Disparities Between Beliefs And Behavior In Pursuing...

medicalnewstoday.com
Sep 25, 2008
        

Despite overwhelming support for early Alzheimer's disease (AD) screening and detection, there are striking differences between intentions and actual behavior, according to a new online survey of 1,040 adults age 55 and...

add comment
                   

Examine the World Imaging Agents (Contrast Media, Radiopharmaceuticals) Market

marketwire.com
Sep 18, 2008 16 related
        

LONDON, UNITED KINGDOM--(Marketwire - Sept. 18, 2008) - Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Imaging Agents (Contrast...

add comment

Pfizer to work with Medivation on Alzheimer's drug Dimebon

marketwatch.com
Sep 3, 2008 25 related
        

Pfizer Inc. announced an agreement to develop and commercialize Medivation Inc.'s Dimebon, an investigational treatment for Alzheimer's and Huntington's diseases, in a deal valued at up to $725 million. The deal comes as...

add comment

Japan's Shionogi to buy Sciele Pharma

ft.com
Sep 1, 2008 34 related
        

TOKYO, Sept 1 - Shionogi & Co, Japan’s sixth-largest drug maker by market value, said it planned to buy U.S.-based Sciele Pharma Inc for $1.4bn as it seeks to expand in the key U.S. market. Shionogi said it will offer...

add comment
                   

Asia markets mixed as Japan falls and HK gains

iht.com
Aug 27, 2008 9 related
        

Asian markets were mixed Wednesday, as Japan stocks fell and Hong Kong shares rose sharply after solid earnings from leading phone company China Mobile Ltd. Tokyo's benchmark Nikkei 225 fell 0.20 percent to 12,752.96. In...

add comment
                   
genengnews.com: Genetic Engineering genengnews.com

Morphotek,(R) Inc. Expands Its Phase II Trial Site Selections in the European Union

genengnews.com
Aug 26, 2008
        

News source: Business Wire Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced that it has opened clinical sites in the European Union (EU) as part of the company's MORAb-009 Phase II...

add comment
1 2 3 4 5 next »